Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Alice Maniatis"'
Autor:
Alice Maniatis, K. Papanastasiou, Anastasia Pouli, Konstantinos Zervas, C. Mitsouli, M. Chatziyianni, V. Perifanis
Publikováno v:
European Journal of Haematology. 57:142-148
Results of studies using IFN-alpha treatment for maintaining remission and prolonging survival in multiple myeloma (MM) are in conflict and trials seeking optimum use for this biological response modifier are continuing. Between 1989 and 1993 a prosp
Publikováno v:
Transfusion. 48:988-1000
Autor:
Alice Maniatis
Publikováno v:
Transfusion Alternatives in Transfusion Medicine. 9:13-18
SUMMARY Intravenous iron has been used extensively in nephrology for decades. However, the rare but serious reactions associated with high-molecular-weight iron dextran administration have resulted in largely unjustified fears over its use, thus limi
Autor:
Konstantinos Zervas, Alice Maniatis, E. Terpos, C. Mitsouli, Meletios A. Dimopoulos, Souzana Delibasi, Marie-Christine Kyrtsonis, A. Anagnostopoulos, N. Anagnostopoulos, D Mihou, Eirini Katodritou, P Zikos, Anastasia Pouli
Publikováno v:
Annals of Oncology. 18:1369-1375
Background: We have previously demonstrated that vincristine, liposomal doxorubicin and dexamethasone (VAD-doxil) is equally effective with VAD-bolus yielding objective response rates of 61% as first-line treatment in multiple myeloma (MM). In a phas
Autor:
Meletios-Athanasios Dimopoulos, Alice Maniatis, Athanasios Anagnostopoulos, Vassiliki Grigoraki, Panagiostis Repoussis, Anastasia Pouli, Nikolaos Anagnostopoulos, Argyris Symeonidis, Konstantinos Zervas, Dimitra Gika, T. Economopoulos
Publikováno v:
European Journal of Haematology. 75:370-375
Objectives: Purpose of this study was to compare prognostic factors and outcome of patients with multiple myeloma (MM) aged >70 yr at diagnosis with those of younger patients. We also applied the recently proposed International Staging System (ISS) f
Autor:
Eleni Theodori, Marina Karakantza, Panagiotis Zikos, Nikolaos C. Giannakoulas, Ioannis C. Metallinos, George Sakellaropoulos, Anthi Aktypi, Nicholas C. Zoumbos, Alice Maniatis, Alexandra Kouraklis
Publikováno v:
International Journal of Hematology. 79:253-259
We investigated endothelial and in vivo platelet activation in a cohort of 52 patients with essential thrombocythemia (ET) and polycythemia vera (PV) before and after cytoreductive treatment, 22 healthy controls, and 17 patients with acute cerebrovas
Autor:
Alice Maniatis, Norbert Müller
Publikováno v:
Transfusion Alternatives in Transfusion Medicine. 6:12-15
SUMMARY Developments in blood transfusion over the last two decades have been wide reaching. The variety of blood components available allows for a much more specific approach to each patient's needs. Safety parameters have to be taken into considera
Autor:
Alexandra Kouraklis-Symeonidis, Nicholas C. Zoumbos, Theodora Kakagianni, Panagiota Matsouka, Nikolaos Giannakoulas, Maria Pagoni, Marina Karakantza, Alice Maniatis, Athanasios Galanopoulos, Georgios L. Theodorou
Publikováno v:
British Journal of Haematology. 124:97-105
Immune dysfunction, which leads to the suppression of haemopoiesis by cytokines that are secreted by activated T lymphocytes, is considered to play a key role in the pathogenesis of acquired aplastic anaemia (AAA). We investigated the intracytoplasmi
Autor:
Ioannis Gianakopoulos, Maria Theodoropoulou, Maria-Christina Kyrtsonis, Vassiliki Vlaha, Alice Maniatis, Athanasia Mouzaki
Publikováno v:
Blood. 100:1774-1779
Childhood idiopathic thrombocytopenic purpura (ITP) resolves usually after the first episode, although it may recur, and in 10% to 20% of patients develops into a chronic disorder. Evidence of the immunoregulatory role of Th1/Th2 responses in autoimm
Autor:
Konstantinos Zervas, Alice Maniatis, D. Barbarousi, Nikolaos Anagnostopoulos, B. Gregoraki, E. Venetis, Meletios-Athanassios Dimopoulos, M. Tzilianos, Anastasia Pouli, Bourantas Kl, N. Vyniou
Publikováno v:
European Journal of Haematology. 66:18-23
OBJECTIVES The purpose of the study was to evaluate, in a selected group of myeloma patients with favorable prognosis, the effect, on response and survival, of polychymotherapy compared with melphalan prednisone, plus interferon in both arms. METHODS